These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3814172)

  • 21. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
    Lehmann J
    Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904
    [No Abstract]   [Full Text] [Related]  

  • 22. Distribution studies of salicylazosulfapyridine and its metabolites.
    Peppercorn MA; Goldman P
    Gastroenterology; 1973 Feb; 64(2):240-5. PubMed ID: 4405598
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycobacterium obuense, a rapidly growing scotochromogenic mycobacterium capable of forming a black product from p-aminosalicylate and salicylate.
    Tsukamura M; Mizuno S
    J Gen Microbiol; 1971 Oct; 68(2):129-34. PubMed ID: 5136244
    [No Abstract]   [Full Text] [Related]  

  • 24. Bacterial acetylation of 5-aminosalicylic acid in faecal suspensions cultured under aerobic and anaerobic conditions.
    van Hogezand RA; Kennis HM; van Schaik A; Koopman JP; van Hees PA; van Tongeren JH
    Eur J Clin Pharmacol; 1992; 43(2):189-92. PubMed ID: 1425876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
    Sandborn WJ; Hanauer SB; Buch A
    Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of aminosalicylic acid and its various salts in humans IV: comparison of four brands of the sodium salt.
    Pentikäinen PJ; Wan SH; Azarnoff DL
    J Pharm Sci; 1974 Sep; 63(9):1431-4. PubMed ID: 4610119
    [No Abstract]   [Full Text] [Related]  

  • 27. The in vivo metabolism of cholesterol by gut bacteria in the rat and guinea-pig.
    Goddard P; Hill MJ
    J Steroid Biochem; 1974 Oct; 5(6):569-72. PubMed ID: 4427454
    [No Abstract]   [Full Text] [Related]  

  • 28. Oroileal transit of slow release 5-aminosalicylic acid.
    Goebell H; Klotz U; Nehlsen B; Layer P
    Gut; 1993 May; 34(5):669-75. PubMed ID: 8504969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Aminosalicylic acid enemas.
    Lancet; 1982 Jan; 1(8263):102. PubMed ID: 6119463
    [No Abstract]   [Full Text] [Related]  

  • 30. [5-Aminosalicylic acid enema preparation].
    René E; Farinotti R; Mignon M; Cerf M; Dauphin A; Bonfils S
    Gastroenterol Clin Biol; 1983 Nov; 7(11):935. PubMed ID: 6653982
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of oxidation products of 5-aminosalicylic acid in faeces and the study of their formation in vitro.
    Jensen J; Cornett C; Olsen CE; Bondesen S; Christensen J; Christensen LA; Tjørnelund J; Hansen SH
    Biochem Pharmacol; 1993 Mar; 45(6):1201-9. PubMed ID: 8385459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral mesalamine formulation to be marketed.
    Clin Pharm; 1993 Aug; 12(8):555. PubMed ID: 8222518
    [No Abstract]   [Full Text] [Related]  

  • 33. [5-aminosalicylic acid and chronic inflammatory bowel diseases in children].
    Klotz U
    Klin Padiatr; 1995; 207(5):285-7. PubMed ID: 7500605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of 5-aminosalicylic acid from Pentasa during normal and accelerated intestinal transit time.
    Christensen LA; Slot O; Sanchez G; Boserup J; Rasmussen SN; Bondesen S; Hansen SH; Hvidberg EF
    Br J Clin Pharmacol; 1987 Mar; 23(3):365-9. PubMed ID: 3567055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reformulation of an aminosalicylate: an example of the importance of pill burden on medical compliance rates.
    Osterman MT; Lichtenstein GR
    Methods Find Exp Clin Pharmacol; 2009; 31(1):41-6. PubMed ID: 19357797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Crohn's disease with peroral 5-aminosalicylic acid.
    Rasmussen SN; Binder V; Maier K; Bondesen S; Fischer C; Klotz U; Hansen SH; Hvidberg EF
    Gastroenterology; 1983 Dec; 85(6):1350-3. PubMed ID: 6354827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mucolytic activity in the cecum of the mouse, rat, golden hamster, guinea pig and rabbit].
    Juhr NC; Haas A
    Z Versuchstierkd; 1976; 18(4):206-15. PubMed ID: 1274484
    [No Abstract]   [Full Text] [Related]  

  • 38. [Salazosulfapyridine or 5-aminosalicylic acid].
    Terpstra JJ
    Ned Tijdschr Geneeskd; 1987 Aug; 131(32):1409-10. PubMed ID: 2889151
    [No Abstract]   [Full Text] [Related]  

  • 39. Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?
    Farrell RJ; Peppercorn MA
    Am J Gastroenterol; 2002 Jun; 97(6):1283-5. PubMed ID: 12094839
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-Aminosalicylic acid for the treatment of inflammatory bowel disease.
    Dew MJ; Evans BK; Rhodes J
    Gastroenterology; 1984 Aug; 87(2):480-1. PubMed ID: 6735091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.